The National, Regional, and Global Impact of Glaucoma As Reported in the 2019 Global Burden of Disease Study

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2023 Dec 7

PMID 38058735

Authors

Huifeng Wu

Yinjun Wang

Feidi Li

Zelong Liu

Feifei Shi

Affiliations

Soon will be listed here.

Abstract

Introduction: We investigated the disability-adjusted life years (DALYs) of glaucoma.

Methods: The estimated annual percentage change (EAPC) was measured to assess trends in the age-standardized DALY rate from 1990 to 2019.

Results: The global age-standardized DALY rate of glaucoma decreased with an EAPC of -1.00. The age-standardized DALY rate decreased least in high-SDI regions. Eastern sub-Saharan Africa had highest age-standardized DALY rate in 2019. At the national level, Mali had the highest age-standardized DALY rate in 2019.

Conclusions: Although the global burden of glaucoma has decreased, the burden remain high in regions with low SDI values and in sub-Saharan Africa.

References

Ocansey S, Kyei S, Diafo A, Darfor K, Boadi-Kusi S, Aglobitse P . Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities. BMC Health Serv Res. 2016; 16:282. PMC: 4950601. DOI: 10.1186/s12913-016-1528-x. View

Burton M, Ramke J, Marques A, Bourne R, Congdon N, Jones I . The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021; 9(4):e489-e551. PMC: 7966694. DOI: 10.1016/S2214-109X(20)30488-5. View

Racette L, Wilson M, Zangwill L, Weinreb R, Sample P . Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003; 48(3):295-313. DOI: 10.1016/s0039-6257(03)00028-6. View

Ono K, Hiratsuka Y, Murakami A . Global inequality in eye health: country-level analysis from the Global Burden of Disease Study. Am J Public Health. 2010; 100(9):1784-8. PMC: 2920965. DOI: 10.2105/AJPH.2009.187930. View

. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1160-1203. PMC: 7566045. DOI: 10.1016/S0140-6736(20)30977-6. View

. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7(2):e105-e125. PMC: 8810394. DOI: 10.1016/S2468-2667(21)00249-8. View

Hernandez R, Burr J, Vale L . Economic evaluation of screening for open-angle glaucoma. Int J Technol Assess Health Care. 2008; 24(2):203-11. DOI: 10.1017/S0266462308080288. View

Philippin H, Matayan E, Knoll K, Macha E, Mbishi S, Makupa A . Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial. Lancet Glob Health. 2021; 9(11):e1589-e1599. PMC: 8526362. DOI: 10.1016/S2214-109X(21)00348-X. View

. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2020; 9(2):e144-e160. PMC: 7820391. DOI: 10.1016/S2214-109X(20)30489-7. View

10.

. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. PMC: 7567026. DOI: 10.1016/S0140-6736(20)30925-9. View

11.

Murdoch I, Smith A, Baker H, Shilio B, Dhalla K . The cost and quality of life impact of glaucoma in Tanzania: An observational study. PLoS One. 2020; 15(6):e0232796. PMC: 7263578. DOI: 10.1371/journal.pone.0232796. View

12.

Freeman E, Roy-Gagnon M, Samson E, Haddad S, Aubin M, Vela C . The global burden of visual difficulty in low, middle, and high income countries. PLoS One. 2013; 8(5):e63315. PMC: 3651198. DOI: 10.1371/journal.pone.0063315. View

13.

Wang W, He M, Li Z, Huang W . Epidemiological variations and trends in health burden of glaucoma worldwide. Acta Ophthalmol. 2019; 97(3):e349-e355. DOI: 10.1111/aos.14044. View

14.

Nduaguba C, Lee R . Glaucoma screening: current trends, economic issues, technology, and challenges. Curr Opin Ophthalmol. 2006; 17(2):142-52. DOI: 10.1097/01.icu.0000193088.75432.c9. View

15.

Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-90. DOI: 10.1016/j.ophtha.2014.05.013. View